View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
July 1, 2020

Fujifilm signs Avigan licensing deal with Dr Reddy’s and GRA

Japan-based Fujifilm has partnered with Indian pharmaceutical firm Dr Reddy’s Laboratories and Global Response Aid (GRA) in Dubai to enable international access to Avigan (favipiravir) as a potential Covid-19 treatment.

Fujifilm Toyama Chemical entered into a tripartite licensing agreement with Dr Reddy’s and GRA for the development, manufacture and sales of Avigan tablets.

Under the agreement, Dr Reddy’s and GRA gain exclusive right to develop, manufacture and sell the drug overseas, excluding China and Russia. Only Dr Reddy’s secured the manufacturing rights.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU